Pathstone Family Office’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-3,000
| Closed | -$13K | – | 347 |
|
|
2018
Q1 | $13K | Buy |
+3,000
| New | +$13K | 0.01% | 206 |
|
|
2017
Q4 | – | Sell |
-3,000
| Closed | -$13K | – | 213 |
|
|
2017
Q3 | $13K | Hold |
3,000
| – | – | 0.01% | 124 |
|
|
2017
Q2 | $11K | Hold |
3,000
| – | – | ﹤0.01% | 311 |
|
|
2017
Q1 | $8K | Buy |
+3,000
| New | +$8K | ﹤0.01% | 306 |
|
|
2016
Q4 | – | Sell |
-3,000
| Closed | -$9K | – | 210 |
|
|
2016
Q3 | $9K | Hold |
3,000
| – | – | 0.01% | 136 |
|
|
2016
Q2 | $12K | Buy |
+3,000
| New | +$12K | 0.01% | 126 |
|